• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗恩病特异性死亡率:日本一家三级转诊中心的 30 年队列研究。

Crohn's disease-specific mortality: a 30-year cohort study at a tertiary referral center in Japan.

机构信息

Department of Gastroenterology, Fukuoka University Chikushi Hospital, 1-1-1 Zokumyoin, Chikushino, Fukuoka, 818-0067, Japan.

Inflammatory Bowel Disease Center, Fukuoka University Chikushi Hospital, Fukuoka, Japan.

出版信息

J Gastroenterol. 2019 Jan;54(1):42-52. doi: 10.1007/s00535-018-1482-y. Epub 2018 Jun 9.

DOI:10.1007/s00535-018-1482-y
PMID:29948302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6314978/
Abstract

BACKGROUND

In this study, survival and cause of death were investigated in patients with Crohn's disease (CD) at a tertiary referral center.

METHODS

A database was created based on the medical records of 1108 CD patients who had a history of visiting our hospital to investigate background characteristics, cumulative survival rates from diagnosis, causes of death, and the standardized mortality ratio (SMR) for each cause of death. A follow-up questionnaire survey of patients followed up inadequately was also conducted. The cumulative survival rate from diagnosis was determined using the life table method and compared with that of a sex- and age-matched population model from the year 2000.

RESULTS

The study included 1108 patients whose mean age at diagnosis was 25.6 ± 10.8 years. The mean duration of follow-up was 14.6 ± 9.4 years, and there were 52 deaths. The cumulative survival rate was significantly lower 25 years after the diagnosis of CD (91.7%) than in the standard population model (95.7%). SMRs for both all causes [3.5; 95% confidence interval (CI): 2.7-4.6] and CD-specific causes (36.7; 95% CI 26.1-51.6) were high. Among the CD-specific causes, SMRs were especially high for small intestine and colorectal cancers, gastrointestinal diseases including intestinal failure (IF), perioperative complications, and amyloidosis.

CONCLUSION

The SMRs for both all causes and CD-specific causes were high in CD patients. CD-specific causes including intestinal cancer, IF, perioperative complications, and amyloidosis showed especially high SMRs.

摘要

背景

本研究旨在某三级转诊中心调查克罗恩病(CD)患者的生存情况和死亡原因。

方法

我们创建了一个数据库,其中包含 1108 例曾在我院就诊的 CD 患者的病历资料,以调查其背景特征、从诊断起的累积生存率、死亡原因以及每种死因的标准化死亡率(SMR)。我们还对随访不充分的患者进行了随访问卷调查。使用寿命表法确定从诊断起的累积生存率,并与 2000 年的性别和年龄匹配人群模型进行比较。

结果

本研究共纳入 1108 例患者,诊断时的平均年龄为 25.6±10.8 岁。平均随访时间为 14.6±9.4 年,共有 52 例死亡。CD 诊断后 25 年的累积生存率明显低于标准人群模型(91.7% vs. 95.7%)。所有原因的 SMR[3.5;95%可信区间(CI):2.7-4.6]和 CD 特异性原因的 SMR(36.7;95% CI 26.1-51.6)均较高。在 CD 特异性原因中,小肠和结直肠癌、包括肠衰竭(IF)在内的胃肠道疾病、围手术期并发症和淀粉样变性的 SMR 尤其高。

结论

CD 患者的所有原因和 CD 特异性原因的 SMR 均较高。CD 特异性原因,包括肠道癌症、IF、围手术期并发症和淀粉样变性,显示出较高的 SMR。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab0/6314978/8694c442939e/535_2018_1482_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab0/6314978/8694c442939e/535_2018_1482_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab0/6314978/8694c442939e/535_2018_1482_Fig1_HTML.jpg

相似文献

1
Crohn's disease-specific mortality: a 30-year cohort study at a tertiary referral center in Japan.克罗恩病特异性死亡率:日本一家三级转诊中心的 30 年队列研究。
J Gastroenterol. 2019 Jan;54(1):42-52. doi: 10.1007/s00535-018-1482-y. Epub 2018 Jun 9.
2
Ulcerative colitis and colorectal cancer: a follow-up study in Fukuoka, Japan.溃疡性结肠炎与结直肠癌:日本福冈的一项随访研究
Int J Epidemiol. 1999 Aug;28(4):609-13. doi: 10.1093/ije/28.4.609.
3
Mortality Trends in Crohn's Disease and Ulcerative Colitis: A Population-based Study in Québec, Canada.克罗恩病和溃疡性结肠炎的死亡率趋势:加拿大魁北克省的一项基于人群的研究
Inflamm Bowel Dis. 2016 Feb;22(2):416-23. doi: 10.1097/MIB.0000000000000608.
4
Mortality and cause of death in Japanese patients with Crohn's disease.日本克罗恩病患者的死亡率及死因
Dis Colon Rectum. 2003 Oct;46(10 Suppl):S15-21. doi: 10.1097/01.DCR.0000087485.03284.D3.
5
Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.克罗恩病相关结直肠癌:一项斯堪的纳维亚基于人群的队列研究。
Lancet Gastroenterol Hepatol. 2020 May;5(5):475-484. doi: 10.1016/S2468-1253(20)30005-4. Epub 2020 Feb 14.
6
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort.克罗恩病:在一项基于全欧洲人群的队列研究中,确诊10年后死亡率升高。
Gut. 2006 Apr;55(4):510-8. doi: 10.1136/gut.2005.072793. Epub 2005 Sep 8.
7
Malignancy in Crohn's disease: incidence and clinical characteristics in Japan.克罗恩病中的恶性肿瘤:日本的发病情况和临床特征。
Digestion. 2010;81(4):265-70. doi: 10.1159/000273784. Epub 2010 Feb 4.
8
General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study.基于人群的炎症性肠病患者队列的总体死亡率和癌症特异性死亡率:佛罗伦萨研究。
Gut. 1998 Feb;42(2):175-9. doi: 10.1136/gut.42.2.175.
9
Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland.溃疡性结肠炎和克罗恩病的死亡率。芬兰的一项基于人群的研究。
J Crohns Colitis. 2012 Jun;6(5):524-8. doi: 10.1016/j.crohns.2011.10.009. Epub 2011 Nov 16.
10
Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark.克罗恩病的死亡率及死亡原因:丹麦哥本哈根郡一项基于人群队列的随访研究
Gastroenterology. 2002 Jun;122(7):1808-14. doi: 10.1053/gast.2002.33632.

引用本文的文献

1
Performance of serum gelsolin as a biomarker for mucosal activity in Crohn's disease: a comparison with C-reactive protein.血清凝溶胶蛋白作为克罗恩病黏膜活性生物标志物的性能:与C反应蛋白的比较。
Therap Adv Gastroenterol. 2025 Aug 19;18:17562848251362570. doi: 10.1177/17562848251362570. eCollection 2025.
2
A nomogram for predicting small bowel mucosal healing in pediatric Crohn's disease.一种用于预测儿童克罗恩病小肠黏膜愈合情况的列线图。
Front Med (Lausanne). 2025 Jun 24;12:1582238. doi: 10.3389/fmed.2025.1582238. eCollection 2025.
3
Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn's disease.

本文引用的文献

1
Secondary systemic amyloidosis in inflammatory bowel disease: a nationwide analysis.炎症性肠病中的继发性系统性淀粉样变性:一项全国性分析。
Ann Gastroenterol. 2017;30(5):504-511. doi: 10.20524/aog.2017.0168. Epub 2017 Jun 14.
2
Overall and cause-specific mortality in Korean patients with inflammatory bowel disease: A hospital-based cohort study.韩国炎症性肠病患者的总体死亡率和特定病因死亡率:一项基于医院的队列研究。
J Gastroenterol Hepatol. 2017 Apr;32(4):782-788. doi: 10.1111/jgh.13596.
3
Total and cancer mortality in a cohort of ulcerative colitis and Crohn's disease patients: The Florence inflammatory bowel disease study, 1978-2010.
用于小肠克罗恩病早期诊断的胶囊内镜评分系统的开发。
J Gastroenterol. 2025 Jun;60(6):705-714. doi: 10.1007/s00535-025-02235-x. Epub 2025 Mar 7.
4
Perianal disease in inflammatory bowel disease: Broadening treatment and surveillance strategies for anal cancer.炎症性肠病的肛周疾病:拓宽肛门癌的治疗和监测策略。
World J Gastroenterol. 2024 Jul 28;30(28):3373-3385. doi: 10.3748/wjg.v30.i28.3373.
5
Hepatic Abscess in Inflammatory Bowel Disease: A Systematic Scoping Review of an Overlooked Entity.炎症性肠病中的肝脓肿:对一个被忽视实体的系统综述。
Saudi J Med Med Sci. 2023 Oct-Dec;11(4):267-274. doi: 10.4103/sjmms.sjmms_545_22. Epub 2023 Oct 6.
6
Usefulness of Serum Leucine-Rich Alpha-2 Glycoprotein as a Surrogate Marker of Small Bowel Mucosal Injury in Crohn's Disease.血清富含亮氨酸的α-2糖蛋白作为克罗恩病中小肠黏膜损伤替代标志物的效用
Inflamm Intest Dis. 2023 Jul 10;8(2):69-76. doi: 10.1159/000531622. eCollection 2023 Oct.
7
Crohn's disease-related anal fistula cancer diagnosed by examination under anesthesia: a case report.通过麻醉下检查诊断的克罗恩病相关肛瘘癌:一例报告
Surg Case Rep. 2023 Aug 23;9(1):149. doi: 10.1186/s40792-023-01722-8.
8
Usefulness of Serum Leucine-rich Alpha 2 Glycoprotein in Crohn's Disease: Is There Any Difference between Small Intestine and Colonic Lesions?血清富含亮氨酸的α2糖蛋白在克罗恩病中的作用:小肠病变与结肠病变之间有差异吗?
Crohns Colitis 360. 2023 May 23;5(3):otad028. doi: 10.1093/crocol/otad028. eCollection 2023 Jul.
9
Diagnostic Features of Perianal Fistula in Patients With Crohn's Disease: Analysis of a Japanese Claims Database.克罗恩病患者肛周瘘管的诊断特征:日本索赔数据库分析
Crohns Colitis 360. 2021 Aug 2;3(3):otab055. doi: 10.1093/crocol/otab055. eCollection 2021 Jul.
10
Mortality in Patients with Inflammatory Bowel Disease: Results from 30 Years of Follow-up in a Norwegian Inception Cohort (the IBSEN study).炎症性肠病患者的死亡率:一项挪威定群研究(IBSEN 研究)30 年随访结果。
J Crohns Colitis. 2023 Apr 19;17(4):497-503. doi: 10.1093/ecco-jcc/jjac156.
溃疡性结肠炎和克罗恩病患者队列中的全因死亡率和癌症死亡率:佛罗伦萨炎症性肠病研究,1978 - 2010年
Dig Liver Dis. 2016 Oct;48(10):1162-7. doi: 10.1016/j.dld.2016.07.008. Epub 2016 Jul 15.
4
Current State of and Problems Related to Cancer of the Intestinal Tract Associated with Crohn's Disease in Japan.日本克罗恩病相关肠道癌的现状及相关问题
Anticancer Res. 2016 Jul;36(7):3761-6.
5
Amyloidosis in Inflammatory Bowel Disease: A Systematic Review of Epidemiology, Clinical Features, and Treatment.炎症性肠病中的淀粉样变性:流行病学、临床特征及治疗的系统评价
J Crohns Colitis. 2016 Oct;10(10):1245-53. doi: 10.1093/ecco-jcc/jjw080. Epub 2016 Apr 7.
6
Short Bowel Syndrome and Intestinal Failure in Crohn's Disease.克罗恩病中的短肠综合征与肠衰竭
Inflamm Bowel Dis. 2016 May;22(5):1209-18. doi: 10.1097/MIB.0000000000000698.
7
Mortality Trends in Crohn's Disease and Ulcerative Colitis: A Population-based Study in Québec, Canada.克罗恩病和溃疡性结肠炎的死亡率趋势:加拿大魁北克省的一项基于人群的研究
Inflamm Bowel Dis. 2016 Feb;22(2):416-23. doi: 10.1097/MIB.0000000000000608.
8
Long-term course of Crohn's disease in Japan: Incidence of complications, cumulative rate of initial surgery, and risk factors at diagnosis for initial surgery.日本克罗恩病的长期病程:并发症发生率、初次手术累积率及诊断时初次手术的危险因素。
J Gastroenterol Hepatol. 2015 Dec;30(12):1713-9. doi: 10.1111/jgh.13013.
9
Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study.2006 - 2012年韩国炎症性肠病的发病率及自然病程:一项基于全国人口的研究
Inflamm Bowel Dis. 2015 Mar;21(3):623-30. doi: 10.1097/MIB.0000000000000313.
10
Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011.炎症性肠病的治疗和手术率变化:1979-2011 年全国队列研究。
Gut. 2014 Oct;63(10):1607-16. doi: 10.1136/gutjnl-2013-305607. Epub 2013 Sep 20.